---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-008311"
form_type: "8-K"
ticker: "AVAH"
cik: "0001832332"
company_name: "Aveanna Healthcare Holdings, Inc."
filed_at: "2023-03-16T23:59:59+00:00"
generated_at: "2026-06-18T00:56:49.551571+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Aveanna Q4 revenue +9% to $451.1M; net loss widens to $237.8M on $87.4M goodwill impairment

## Summary
- Q4 revenue $451.1M (+9% YoY); net loss $237.8M vs $126.2M loss in Q4 2021 due to $87.4M impairment.
- Adjusted EBITDA $29.7M (6.6% margin), down 35% from $45.8M (11.1% margin) a year ago.
- FY 2022 revenue $1,787.6M (+6.5%); net loss $662.0M, including $557.6M non-cash impairment charges.
- FY 2022 adjusted EBITDA $129.3M vs $184.2M; adjusted EPS $0.00 vs $0.42 in FY 2021.
- Cash $19.2M; revolver undrawn with $180M capacity; free cash flow deficit $81.5M for FY 2022.

## SEC filing metadata
- accession: 0000950170-23-008311
- form_type: 8-K
- ticker: AVAH
- cik: 0001832332
- company_name: Aveanna Healthcare Holdings, Inc.
- filed_at: 2023-03-16T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832332/000095017023008311/0000950170-23-008311-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832332/000095017023008311/avah-20230316.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-008311
- JSON: https://secwatch.observer/filing/0000950170-23-008311.json
- Plain text: https://secwatch.observer/filing/0000950170-23-008311.txt

## Key facts
- Earnings Releases
  Aveanna Healthcare Holdings, Inc. reported the three-month period ended December 31, 2022 results: revenue $451.1 million, net income $237.8 million, EPS $1.28.
  - Period: the three-month period ended December 31, 2022
  - Revenue: $451.1 million
  - Net income: $237.8 million
  - EPS: $1.28
  - Result: reported results
  source text: Revenue was $451.1 million for the three-month period ended December 31, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832332/000095017023008311/0000950170-23-008311-index.htm
- Earnings Releases
  Aveanna Healthcare Holdings, Inc. reported the three-month period and fiscal year ended December 31, 2022 results: revenue $451.1 million, net income $237.8 million, EPS $1.28.
  - Period: the three-month period and fiscal year ended December 31, 2022
  - Revenue: $451.1 million
  - Net income: $237.8 million
  - EPS: $1.28
  - Result: reported results
  source text: Item 2.02. --- EX-99 (EX-99.1) --- EX-99 Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS • Revenue increased 9.0% to $451.1 million, compared to Q4 2021 o Gross margin increased 3.5% to $128.8 million, compared to Q4 2021 • Net loss was $237.8 million, compared to net loss of $126.2 million in Q4 2021 o
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832332/000095017023008311/0000950170-23-008311-index.htm
- Earnings Releases
  Aveanna Healthcare Holdings, Inc. reported the fiscal year ended December 31, 2022 results: revenue $1,787.6 million, net income $662.0 million, EPS $3.57.
  - Period: the fiscal year ended December 31, 2022
  - Revenue: $1,787.6 million
  - Net income: $662.0 million
  - EPS: $3.57
  - Result: reported results
  source text: Revenue was $1,787.6 million for the fiscal year ended December 31, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832332/000095017023008311/0000950170-23-008311-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.